Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NASDAQInformation TechnologyConsumer ElectronicsSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for VUZI yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Stabilize leadership and execute growth initiatives | A supporting condition in Vuzix Corp.'s published investment case. The stated target is No further major executive departures in next 4 quarters. | Under Pressure | Major executive departures occur within next 4 quarters | 1 major executive departure vs 0 allowed Form 8-K filed April 24, 2026, confirms the departure of Chris Parkinson, President of Enterprise Solutions, by mutual agreement. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 12, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
VUZI is a high-risk, loss-making growth story, not an established compounder. Its thesis is in a watch state: the signal has turned cautious as company momentum weakened, though the evidence does not show a fresh break in the thesis.
The valuation model shows VUZI at a premium to peers, with optionality as the main source of that gap. The expectations gap is positive, but model confidence is low; the snapshot describes the premium as unjustified and overall fragility as low.
Near term, recent results point to weak fundamentals: revenue fell year over year in both reported 2026 quarters, product sales declined, and gross losses persist. Management is investing in waveguide capacity and research, but diversification and branded product priorities have yet to show stronger revenue; recent earnings beats do not erase that mixed record.
Over the next several quarters, the key test is whether OEM, defense, and waveguide programs broaden revenue enough to support the ongoing investment. Further guidance cuts would add pressure, while stabilizing technology-sector results or lower interest rates could provide a more supportive backdrop, but would not resolve company-specific execution risks.
For the 1-to-3-year view, VUZI remains a speculative, execution-dependent business with expensive peer-relative valuation, declining revenue, and persistent losses. The thesis hinges on strategic investments becoming sustained business growth. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Move towards positive EPS |
| A primary condition in Vuzix Corp.'s published investment case. The stated target is EPS >= 0. |
| Broken |
| EPS remains negative over next 4 quarters |
Diluted EPS: $-0.09 per share FY2026-Q2; GAAP. Published target: EPS >= 0. Target period is not explicitly aligned with this observation. Aug 13, 2026-0.09 USD/share · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Sustain at least 7% revenue growth | A primary condition in Vuzix Corp.'s published investment case. The stated target is >=7% YoY revenue growth. | Broken | YoY revenue growth falls below 7% in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-0.33 → $-0.33 · observed estimates
$0.01B → $0.01B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-08-18 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-08-19 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-08-20 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-08-21 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-08-22 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-08-23 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-08-24 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-08-25 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-08-26 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-08-27 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-08-28 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-08-29 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-08-30 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-08-31 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-01 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-02 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-03 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-04 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-05 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-06 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-07 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-08 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-09 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-10 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-11 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-12 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-13 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-14 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-15 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-16 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-17 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-18 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-19 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-20 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-21 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-22 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-23 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-24 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-25 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-26 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-27 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-28 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-29 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-09-30 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-01 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-02 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-03 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-04 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-05 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-06 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-07 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-08 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-09 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-10 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-11 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-12 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-13 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-14 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-15 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-16 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-17 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-18 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-19 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-20 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-21 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-22 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-23 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-24 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-25 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-26 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-27 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-28 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-29 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-30 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-10-31 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-11-01 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-11-02 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-11-03 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-11-04 | $-0.33 | $11,500,000 | 1 / 1 |
| 2026-11-05 | $-0.33 | $11,500,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.